Effect of small nuclear ribonucleoprotein-associated polypeptide N on the proliferation of medulloblastoma cells
Related Experiment Video
Updated: Apr 18, 2026

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
Published on: September 1, 2010
Junjie Jing1, Yang Zhao2, Chengfeng Wang3
1Department of Neurosurgery, Fuzhou General Hospital of Nanjing Military Region, Fuzhou, Fujian 350025, P.R. China.
Abstract:
Spliceosome mutations have been reported in various types of cancer and a number of antitumor drugs have been observed to tightly bind to spliceosome components. Small nuclear ribonucleoprotein‑associated polypeptide N (SNRPN) is a small ribonuclear protein and is a key spliceosome constituent. However, the role of SNRPN in human medulloblastoma remains unknown. In the present study, the effect of SNRPN on cell growth was investigated in vitro using the Daoy human medulloblastoma cell line. Lentivirus (Lv)-mediated short hairpin (sh) RNA was used to silence SNRPN expression, which was verified by reverse transcription‑quantitative polymerase chain reaction and western blotting. Cell proliferation was examined by MTT and colony formation assays. Knockdown of SNRPN markedly reduced the proliferation and colony formation ability of Daoy medulloblastoma cells. In addition, flow cytometric analysis revealed that the cell cycle distribution was altered when the Daoy cells were infected with Lv‑shSNRPN. To the best of our knowledge, this is the first study to investigate the effect of SNRPN on cell proliferation in medulloblastoma. The results indicate that SNRPN may be a potential novel target for the development of pharmacological therapeutics in human medulloblastoma.
Insights
Small nuclear ribonucleoprotein-associated polypeptide N (SNRPN) knockdown inhibits medulloblastoma cell growth and proliferation. This study identifies SNRPN as a potential therapeutic target for human medulloblastoma.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Spliceosome mutations are implicated in various cancers, with some drugs targeting spliceosome components.
- Small nuclear ribonucleoprotein-associated polypeptide N (SNRPN) is a crucial spliceosome component, but its role in medulloblastoma is uncharacterized.
Purpose of the Study:
- To investigate the effect of SNRPN on cell growth and proliferation in human medulloblastoma.
- To determine if SNRPN could be a potential therapeutic target for medulloblastoma.
Main Methods:
- Utilized lentivirus (Lv)-mediated short hairpin (sh) RNA to silence SNRPN expression in Daoy medulloblastoma cells.
- Verified SNRPN knockdown using reverse transcription-quantitative polymerase chain reaction and western blotting.
- Assessed cell proliferation via MTT and colony formation assays, and analyzed cell cycle distribution using flow cytometry.
Main Results:
- SNRPN knockdown significantly reduced the proliferation and colony formation of Daoy medulloblastoma cells.
- Altered cell cycle distribution was observed in Daoy cells following SNRPN silencing.
- This is the first study to demonstrate the impact of SNRPN on medulloblastoma cell proliferation.
Conclusions:
- SNRPN plays a significant role in medulloblastoma cell growth and proliferation.
- SNRPN represents a promising novel target for developing pharmacological therapies for human medulloblastoma.
Related Concept Videos
Abnormal Proliferation
The Nucleolus
Negative Regulator Molecules
Regulation of Nuclear Protein Sorting

